[{"AccountsPayableCurrent_0_Q2_USD":151800000.0,"OperatingIncomeLoss_2_Q2_USD":109900000.0,"OperatingLeaseExpense_1_Q2_USD":300000.0,"OperatingLeaseExpense_2_Q2_USD":700000.0,"OperatingLeaseLeaseIncome_1_Q2_USD":16900000.0,"OperatingLeaseLeaseIncome_2_Q2_USD":35600000.0,"OperatingLeaseLiability_0_Q2_USD":31600000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5700000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":25900000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":29600000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q2_USD":1500000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":2800000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.04,"OtherAssetsNoncurrent_0_Q2_USD":109900000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":1500000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":4600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":500000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-1700000.0,"OperatingIncomeLoss_1_Q2_USD":14500000.0,"OperatingCostsAndExpenses_2_Q2_USD":630600000.0,"OperatingCostsAndExpenses_1_Q2_USD":383000000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_1_Q2_USD":400000.0,"LeaseCost_2_Q2_USD":3500000.0,"Liabilities_0_Q2_USD":1371500000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2915200000.0,"LiabilitiesCurrent_0_Q2_USD":377800000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":49500000.0,"LongTermDebt_0_Q2_USD":863600000.0,"LongTermDebtCurrent_0_Q2_USD":28800000.0,"LongTermDebtNoncurrent_0_Q2_USD":825200000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":2900000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-26000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24600000.0,"NetIncomeLoss_2_Q2_USD":74300000.0,"NetIncomeLoss_1_Q2_USD":4600000.0,"NonoperatingIncomeExpense_1_Q2_USD":-7300000.0,"NonoperatingIncomeExpense_2_Q2_USD":-17500000.0,"NotesPayableCurrent_0_Q2_USD":28800000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_2_Q2_USD":-100000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-123100000.0,"LeaseCost_1_Q2_USD":1800000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":2000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":61400000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":101400000.0,"RestrictedCashCurrent_0_Q2_USD":200000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":801200000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":740500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":397500000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":1400000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":91200000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":172100000.0,"ShareBasedCompensation_2_Q2_USD":21900000.0,"StockholdersEquity_0_Q2_USD":1543700000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":14300000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":19500000.0,"TreasuryStockShares_0_Q2_shares":1200000.0,"TreasuryStockValue_0_Q2_USD":39600000.0,"UnbilledContractsReceivable_0_Q2_USD":51600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":54000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":54300000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":48900000.0,"RepaymentsOfMediumTermNotes_2_Q2_USD":11300000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":0.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":10600000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-2000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1300000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-400000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":1100000.0,"PaymentForContingentConsiderationLiabilityInvestingActivities_2_Q2_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":13000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":123100000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OtherLiabilitiesCurrent_0_Q2_USD":100200000.0,"PreferredStockSharesAuthorized_0_Q2_shares":15000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":66100000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":10000000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1031200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":743500000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_Q2_USD":-3000000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1_Q2_USD":-1600000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":53600000.0,"InventoryWriteDown_1_Q2_USD":41500000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q2_USD":174300000.0,"CapitalizedContractCostAmortization_1_Q2_USD":1600000.0,"CapitalizedContractCostAmortization_2_Q2_USD":1600000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":447500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":447700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-173800000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CommonStockSharesIssued_0_Q2_shares":54900000.0,"CommonStockSharesOutstanding_0_Q2_shares":53700000.0,"CommonStockValue_0_Q2_USD":100000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":6600000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":77200000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q2_USD":39700000.0,"ContractWithCustomerLiability_0_Q2_USD":103400000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":54500000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":48900000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":227800000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":31700000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":5000000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":33100000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":38100000.0,"AccountsReceivableNetCurrent_0_Q2_USD":261900000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":33800000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":287700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-22400000.0,"AdditionalPaidInCapital_0_Q2_USD":804400000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11400000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":21900000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":3400000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":327100000.0,"AmortizationOfFinancingCosts_2_Q2_USD":2000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":30000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":500000.0,"Assets_0_Q2_USD":2915200000.0,"AssetsCurrent_0_Q2_USD":1162100000.0,"AssetsFairValueDisclosure_0_Q2_USD":322500000.0,"BilledContractReceivables_0_Q2_USD":210300000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":1700000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":15100000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":141700000.0,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":9600000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":53200000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2600000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":18100000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":8000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":34700000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-55400000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":400000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-21400000.0,"IncreaseDecreaseInInventories_2_Q2_USD":79700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":800000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":633100000.0,"InterestExpense_1_Q2_USD":8600000.0,"InterestExpense_2_Q2_USD":17100000.0,"InterestPaidNet_2_Q2_USD":15500000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":70400000.0,"InventoryNet_0_Q2_USD":386400000.0,"IncomeTaxesPaid_2_Q2_USD":50300000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":92400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":7200000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-100000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":61900000.0,"DerivativeLiabilities_0_Q2_USD":11400000.0,"EarningsPerShareBasic_1_Q2_USD":0.09,"EarningsPerShareBasic_2_Q2_USD":1.4,"EarningsPerShareDiluted_1_Q2_USD":0.09,"EarningsPerShareDiluted_2_Q2_USD":1.37,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.26,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.26,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-3200000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-100000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":5500000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":-1100000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2_Q2_USD":21700000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":38100000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":199000000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":832100000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":633100000.0,"Goodwill_0_Q2_USD":266600000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":63200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":53500000.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210730"}]